Skip to main content

Table 2 The major Staphylococcus aureus resistance rate (%) during 2022Q1 to 2023Q2

From: Epidemiologic analysis of antimicrobial resistance in hospital departments in China from 2022 to 2023

 

2022Q1

2022Q2

2022Q3

2022Q4

2023Q1

2023Q2

Azithromycin

71.4

52.9

60

63.2

82.6

59.1

Erythromycin

71.4

58.8

60

63.2

82.6

59.1

Clarithromycin

61.9

52.9

60

63.2

82.6

59.1

Penicillin

100

88.2

100

100

91.3

100